Pinnacle Bancorp’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-83
Closed -$21.8K – 928
2025
Q3
$21.8K Hold
83
– – 0.01% 607
2025
Q2
$18.2K Hold
83
– – 0.01% 614
2025
Q1
$18.6K Buy
+83
New +$22.9K 0.01% 595

Other funds holding WST

Pinnacle Bancorp's WST Position: Q4 2025 in Review

Pinnacle Bancorp sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 83 shares — an estimated $21.8K sold.

Pinnacle Bancorp first reported a position in WST in Q1 2025 and held it in 3 quarters. The position peaked at $21.8K in Q3 2025. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Pinnacle Bancorp reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Pinnacle Bancorp sold 83 West Pharmaceutical shares in Q4 2025, an estimated $21.8K.
  • Pinnacle Bancorp first reported a position in West Pharmaceutical in Q1 2025 and held it in 3 quarters.
  • Pinnacle Bancorp's West Pharmaceutical position peaked at $21.8K in Q3 2025.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Pinnacle Bancorp's 13F filing for Q4 2025, filed 22 Jan 2026.